BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer

Valanparambil, RM; Lai, LL; Johns, MA; Davis-Gardner, M; Linderman, SL; McPherson, TO; Chang, AD; Akhtar, A; Gamarra, ELB; Matia, H; McCook-Veal, AA; Switchenko, J; Nasti, TH; Green, F; Saini, M; Wieland, A; Pinsky, BA; Solis, D; Dhodapkar, MV; Carlisle, J; Ramalingam, S; Ahmed, R; Suthar, MS

Suthar, MS (通讯作者),Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.;Suthar, MS (通讯作者),Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.;Suthar, MS (通讯作者),Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.;Suthar, MS (通讯作者),Emory Natl Primate Res Ctr, Atlanta, GA 30329 USA.

NPJ VACCINES, 2023; 8 (1):

Abstract

This study reports that most patients with NSCLC had a significant increase in the nAb response to the currently circulating Omicron variants after bi......

Full Text Link